OGC
CELG

Oak Grove Capital’s Celgene Corp CELG Stock Holding History

Oak Grove Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,250
Closed -$401K – 77
2019
Q1 		$401K Sell
4,250
-200
-4% -$17.5K 0.25% 56
2018
Q4 		$285K Sell
4,450
-5,300
-54% -$391K 0.25% 52
2018
Q3 		$873K Hold
9,750
– – 0.75% 29
2018
Q2 		$774K Buy
9,750
+600
+7% +$49.8K 0.79% 27
2018
Q1 		$816K Buy
9,150
+5,450
+147% +$523K 0.9% 23
2017
Q4 		$386K Buy
+3,700
New +$417K 0.4% 44

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Oak Grove Capital's CELG Position: Q2 2019 in Review

Oak Grove Capital sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 4,250 shares — an estimated $401K sold.

Oak Grove Capital first reported a position in CELG in Q4 2017 and held it in 6 quarters. The position peaked at $873K in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Oak Grove Capital reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Oak Grove Capital sold 4,250 Celgene Corp shares in Q2 2019, an estimated $401K.
  • Oak Grove Capital first reported a position in Celgene Corp in Q4 2017 and held it in 6 quarters.
  • Oak Grove Capital's Celgene Corp position peaked at $873K in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Oak Grove Capital's 13F filing for Q2 2019, filed 9 Aug 2019.